Tornier (TRNX)
Tornier Revenues: 74.46M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
TRNX Revenues Rankings
| Overall | 42nd percentile | 2559 of 4431 |
| Sector | 64th percentile | 165 of 471 in Healthcare |
| Industry | 66th percentile | 23 of 68 in Medical Instruments & Supplies |
TRNX Revenues Range, Past 5 Years
| Minimum | 49.71M | Sep 2010 |
| Maximum | 144.14M | Sep 2009 |
| Average | 70.42M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these TRNX related companies
TRNX News
Tornier to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 01, 8:00AM Business Wire
May 01, 8:00AM Business Wire
Benchmark Starts Tornier (TRNX) at Speculative Buy; Global Player with a Diversified Product Mix
Mar 23, 7:16AM Street Insider
Mar 23, 7:16AM Street Insider
Tornier N.v. (TRNX) Reports In-Line Q4 EPS Loss of $0.05, Offers Q1 and FY12 Sales Guidance
Feb 23, 4:22PM Street Insider
Feb 23, 4:22PM Street Insider
$TRNX 200 Day SMA Cross - Price crossed above 200 day SMA (22.4049). Confirmed by volume.
about 99 days ago by TradeIdeasQuant
about 99 days ago by TradeIdeasQuant
Tornier to Present at the 2012 RBC Capital Markets Healthcare Conference
Feb 21, 8:00AM Business Wire
Feb 21, 8:00AM Business Wire
Tornier to Highlight Products and Education Programs at American Academy of Orthopedic Surgeons (AAOS) Meeting
Feb 08, 8:00AM Business Wire
Feb 08, 8:00AM Business Wire
Tornier (TRNX) Offers Q4 and FY11 Preliminary Sales Results Above Expectations
Jan 09, 8:04AM Street Insider
Jan 09, 8:04AM Street Insider
Tornier Announces Preliminary Fourth Quarter Sales Gain of 12.7% and Full Year 2011 Sales Gain of 14.9%
Jan 09, 8:00AM Business Wire
Jan 09, 8:00AM Business Wire
Tornier to Present at the 30th Annual J.P. Morgan Healthcare Conference
Dec 23, 8:00AM Business Wire
Dec 23, 8:00AM Business Wire
$TRNX
Tornier Reports Q2 EPS $(0.07) vs $(0.07) Est; Revenue $65.2M vs $64.81M E
about 297 days ago by Benzinga
about 297 days ago by Benzinga
$TRNX http://chart.ly/aklkxfh Trying to break out from a early stage base - Watching the 30 level
about 328 days ago by flare9x
about 328 days ago by flare9x
Healthcare Stocks at the All-Time High List via @ivanhoff $RMTI $TRNX $HLF $HSTM http://stk.ly/lzrJ6V
about 387 days ago by chartly
about 387 days ago by chartly
Cramer talked about a joint replacement medical device stock, $TRNX instead - recently rated outperform. $MAKO could still take a bounce.
about 441 days ago by abubnic
about 441 days ago by abubnic
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TRNX | 19.78 | +0.03 | +0.15% | 776.37M |
| TRNS | 7.95 | +0.00 | +0.00% | 58.27M |
| TRNO | 14.00 | -0.22 | -1.55% | 190.12M |
| TRN | 23.72 | -0.98 | -3.97% | 1.981B |
| TRMD | 0.3373 | +0.05 | +18.77% | 24.56M |
| TRMB | 45.59 | -1.57 | -3.34% | 5.883B |
| TRLG | 28.49 | -0.84 | -2.86% | 747.33M |
| TOF | 1.68 | +0.12 | +7.69% | 8.702M |
| TNS | 17.60 | -0.28 | -1.57% | 463.27M |
| TNP | 5.09 | -0.26 | -4.86% | 246.90M |
